ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Business

Japan's Ship Healthcare to run hospital in Bangladesh

OSAKA -- Hospital construction and renovation consultancy Ship Healthcare Holdings will start managing hospitals in emerging Asian markets, first in the Bangladeshi capital of Dhaka.

     The Osaka-based company will form a joint venture as early as September with Aichi Hospital Group, a unit of a leading local conglomerate. Ship Healthcare will take a 60% stake with an investment of some 5 billion yen ($48.4 million).

     The joint venture will renovate a large Aichi-owned hospital to nearly double the number of beds to 650. Operating rooms and intensive care units will get cutting-edge medical equipment. The hospital will handle such advanced treatments as neurosurgery and cardiac surgery. A restaurant and a library will be set up there as well.

     With income levels in Bangladesh growing, demand for state-of-the-art medical care is expected to increase.

     The Japanese company has also recently invested in the operator of Parami Hospital, a Myanmar facility also offering emergency care. The Yangon hospital will handle dialysis and cancer screenings and start seeing patients soon.

     Ship Healthcare aims to generate consolidated sales of 1 trillion yen in the future, ringing up 400 billion yen of this in Asia. A group company runs a showroom for advanced operating rooms in Jakarta, Indonesia.

     The Japanese consultancy logged consolidated sales of 259.1 billion yen for the year ended March through wide-ranging operations including nursing homes and pharmacies. Its hospital construction consulting business, which includes design and medical equipment sales, generated 96 billion yen. It has recently received orders to remodel hospitals in Mongolia and Iraq as well.

(Nikkei)

 

 

 

 

 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media